Services
Our engagements fall into four practice areas, which follow the order of the work: advice before the imaging begins, the analysis of the images, work for the companies that make the instruments, and the discovery biology around the imaging. Each row states the decision the engagement supports, what is delivered and how long it usually takes. Fees are quoted in a written proposal after an introductory call.
Imaging advisory
| Engagement | Decision it supports | Deliverable | Typical duration |
|---|---|---|---|
| Imaging Assay and Platform Advisory | Which microscope, modality and assay design to use, and how to screen with the assay and validate it | A written recommendation, an imaging assay design or a validation plan | Set in the proposal |
Image analysis services
| Engagement | Decision it supports | Deliverable | Typical duration |
|---|---|---|---|
| Image Analysis Service | What the images from a study show, in results that can be reported. | Quantified results, a methods report and the analysis record | Set in the proposal |
| Imaging Pipeline and Analysis Build | Whether to bring the analysis of a cell-based assay in house. | A working analysis in the client's lab, a validation summary, training and a written procedure | 3 to 5 weeks |
| Imaging and Functional Readout Audit | Whether an existing readout can be relied on. | Readout Audit Report, 10 to 20 pages | 1 to 2 weeks |
Imaging and instrument companies
| Engagement | Decision it supports | Deliverable | Typical duration |
|---|---|---|---|
| Imaging Assay and Platform Advisory | Which drug discovery applications to support, and how to substantiate a product claim for pharma users | Application science advice, validation study designs and application notes | Set in the proposal |
| Technical Writing | How to present a product or a study to pharma scientists. | Application notes, technical articles, web content and white papers | Set in the proposal |
Discovery biology programs
| Engagement | Decision it supports | Deliverable | Typical duration |
|---|---|---|---|
| Fractional Lead Biologist | Who is responsible for in vitro strategy before the company makes a full-time hire. | A standing role, with a monthly memo on progress and decisions | Monthly retainer, three-month minimum |
| Assay Cascade Design Sprint | Which assays to run, in what order, and which results move the program forward. | Cascade Design Dossier, 15 to 30 pages | 2 to 3 weeks |
| Human Cell Model Build Advisory | Which human cell model to build or buy for the program's question. | Model Design Package and validation plan | 4 to 8 weeks, in two phases |
| PD Biomarker and Target-Engagement Plan | Which biomarker assays will inform the first-in-human decision. | PD Biomarker Plan | 2 to 3 weeks |
| CRO Selection and Study Oversight | Which CRO should run a study, and whether its data can be relied on. | RFP pack and scored shortlist, then a weekly QC log | Selection about 2 weeks; oversight for the length of the study |
| Scientific Diligence Memo | Whether a data package supports an investment or a partnering decision. | Diligence Memo, 8 to 15 pages, with a red-flag table | 3 to 10 business days |
Book a 30-minute call You answer a few short questions and choose a time. On the call we discuss your work and the decision you need to make.